Screener
Lexeo Therapeutics, Inc. LXEO Q4 2025 Annual earnings
Reported March 30, 2026 · Before market open
EPS-$0.27Beat by $0.05
EPS estimate-$0.32
Next report
Dec 14, 2026 (in 3 months)EPS estimate-$0.33
Versus estimates
Diluted EPS
FAQ
- When did Lexeo Therapeutics, Inc. report Q4 2025 earnings?
- Lexeo Therapeutics, Inc. (LXEO) reported Q4 2025 earnings on March 30, 2026 before market open.
- What were Lexeo Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Lexeo Therapeutics, Inc. reported eps of $-0.27 for Q4 2025.
- Did Lexeo Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.32 by $0.05.
- How did Lexeo Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 65.4% from $-0.78.
- Where can I find Lexeo Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-131792) and the 10-K periodic report (0001193125-26-132085) directly on SEC EDGAR. The filing index links above go to sec.gov.
